Trials / Completed
CompletedNCT02655107
Non-invasive Measurement of Hemoglobin in Infants and Neonates
Non-invasive Measurement of Hemoglobin in Infants and Neonates: Comparison With CO-oximetrie and Point-of-care Devices.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- University Hospital Schleswig-Holstein · Academic / Other
- Sex
- All
- Age
- 1 Month – 2 Years
- Healthy volunteers
- Not accepted
Summary
Non-invasive measurement of hemoglobin in infants and neonates scheduled for elective congenital heart surgery, weighing between 3kg and 20 kg. SpHb measurement will be compared to the gold standard of hemoglobin measurement - CO-oximetrie - and to the point-of-care (GEM 3500 premiere).
Detailed description
Non-invasive measurement of hemoglobin in infants and neonates scheduled for elective congenital heart surgery, weighing between 3kg and 20 kg. SpHb measurement will be compared to the gold standard of hemoglobin measurement - CO-oximetrie - and to the point-of-care (GEM 3500 premiere). Data collection whenever an arterial blood gas analysis is indicated by the experienced attending anesthetist - before and after cardiopulmonary bypass.
Conditions
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-07-01
- Completion
- 2016-08-01
- First posted
- 2016-01-13
- Last updated
- 2016-12-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02655107. Inclusion in this directory is not an endorsement.